L&K Biomed Ltd. (KOSDAQ: 156100)

L&K Biomed Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 17, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	147,731	202,956	107,379	143,972	505,923	73,024
Market Cap Growth	-20.45%	89.01%	-25.42%	-71.54%	592.81%	-2.93%
Enterprise Value	144,793	200,512	115,624	150,234	520,503	108,870
Last Close Price	7410.00	10180.00	7212.36	9679.51	35296.46	6311.94
Forward PE	-	25.02	25.02	25.02	25.02	25.02
PS Ratio	4.46	6.79	5.43	9.37	26.14	2.75
PB Ratio	3.89	6.64	9.98	5.81	14.81	2.05
P/TBV Ratio	3.78	5.87	9.29	6.19	16.57	2.71
P/OCF Ratio	-	-	-	-	-	117133.09
EV/Sales Ratio	4.36	6.70	5.85	9.77	26.89	4.10
EV/EBITDA Ratio	29.97	46.12	-	-	-	-
EV/EBIT Ratio	70.72	98.58	-	-	-	-
Debt / Equity Ratio	0.68	0.44	2.34	0.91	0.59	0.73
Debt / EBITDA Ratio	4.34	3.11	-	-	-	-
Asset Turnover	0.47	0.52	0.35	0.26	0.30	0.32
Inventory Turnover	0.23	0.24	0.33	0.48	0.31	0.72
Quick Ratio	0.85	1.04	0.50	1.69	0.58	0.74
Current Ratio	1.53	1.95	0.95	3.01	1.63	1.42
Return on Equity (ROE)	-14.74%	-25.34%	-91.33%	-46.30%	-30.56%	-26.41%
Return on Assets (ROA)	2.07%	2.20%	-14.22%	-16.15%	-3.69%	-7.09%
Return on Capital (ROIC)	2.70%	3.18%	-19.14%	-18.84%	-4.16%	-8.37%
Earnings Yield	-1.01%	-0.92%	-12.69%	-6.72%	-2.12%	-14.74%
FCF Yield	-8.10%	-1.68%	-6.22%	-7.29%	-0.54%	-0.79%
Buyback Yield / Dilution	-37.35%	-21.04%	-0.07%	-12.57%	-14.15%	-5.11%
Total Shareholder Return	-37.35%	-21.04%	-0.07%	-12.57%	-14.15%	-5.11%

Source: S&P Capital IQ. Standard template. Financial Sources.